A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides. | |
Liu H; Pang G; Ren J; Zhao Y; Wang J. | |
刊名 | Acta Pharm Sin B
![]() |
2017 | |
卷号 | Vol.7 No.2页码:223-229 |
关键词 | 1-(2,4-Bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides ASBT inhibitors Bile acids Cholesterol-lowering drug NC-1 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2003618 |
专题 | 河北省人民医院 |
作者单位 | 1.Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. 2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, China. 3.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, China |
推荐引用方式 GB/T 7714 | Liu H,Pang G,Ren J,et al. A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides.[J]. Acta Pharm Sin B,2017,Vol.7 No.2:223-229. |
APA | Liu H,Pang G,Ren J,Zhao Y,&Wang J..(2017).A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides..Acta Pharm Sin B,Vol.7 No.2,223-229. |
MLA | Liu H,et al."A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides.".Acta Pharm Sin B Vol.7 No.2(2017):223-229. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论